RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+25.49%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$6.11B
AUM Growth
+$6.11B
(+61%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
31.4%
Top 10 Holdings %
Top 10 Hldgs %
63.75%
Holding
76
New
9
Increased
16
Reduced
14
Closed
12
Top Buys
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$2.03B |
| 2 |
Vistra
VST
|
$94.6M |
| 3 |
United Airlines
UAL
|
$63.5M |
| 4 |
Treehouse Foods
THS
|
$48M |
| 5 |
Delek US
DK
|
$37.5M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$65.8M |
| 2 |
Dave & Buster's
PLAY
|
$48.8M |
| 3 |
Mr. Cooper
COOP
|
$44.5M |
| 4 |
NCR Voyix
VYX
|
$42.4M |
| 5 |
Collegium Pharmaceutical
COLL
|
$41.9M |
Sector Composition
| 1 | Utilities | 39.64% |
| 2 | Healthcare | 32.73% |
| 3 | Technology | 5.22% |
| 4 | Industrials | 5.16% |
| 5 | Energy | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $60.5M | 0.99% |
2,419,103
| – | – |
|
27
Extreme Networks
EXTR
$2.87B
| $59.1M | 0.96% |
3,931,913
-1,322,831
| -25% | -$19.9M |
|
28
Avis
CAR
$5.53B
| $58.9M | 0.96% |
672,406
-17,867
| -3% | -$1.56M |
|
29
TransAlta
TAC
$3.57B
| $58.3M | 0.95% |
5,622,961
+935,803
| +20% | +$9.69M |
|
30
Orthofix Medical
OFIX
$583M
| $57.7M | 0.94% |
3,694,946
| – | – |
|
31
Adeia
ADEA
$1.67B
| $55.3M | 0.9% |
4,640,009
| – | – |
|
32
Heron Therapeutics
HRTX
$204M
| $53.2M | 0.87% |
26,713,503
| – | – |
|
33
Stratasys
SSYS
$863M
| $51.4M | 0.84% |
6,191,000
+222,297
| +4% | +$1.85M |
|
34
Zymeworks
ZYME
$1.07B
| $49.2M | 0.8% |
3,917,331
| – | – |
|
|
35
Collegium Pharmaceutical
COLL
$1.25B
| $48.3M | 0.79% |
1,250,000
-1,083,500
| -46% | -$41.9M |
|
|
36
Treehouse Foods
THS
$917M
| $48M | 0.78% |
+1,143,664
| New | +$48M |
|
37
Xperi
XPER
$272M
| $38.3M | 0.62% |
4,143,744
| – | – |
|
38
Teladoc Health
TDOC
$1.37B
| $37.9M | 0.62% |
4,126,624
-501,908
| -11% | -$4.61M |
|
|
39
Delek US
DK
$1.92B
| $37.5M | 0.61% |
+2,000,000
| New | +$37.5M |
|
40
GoodRx Holdings
GDRX
$1.49B
| $32.5M | 0.53% |
4,680,028
+943,226
| +25% | +$6.55M |
|
41
AAR Corp
AIR
$2.72B
| $30.8M | 0.5% |
471,699
-103,301
| -18% | -$6.75M |
|
42
FTAI Infrastructure
FIP
$479M
| $29.5M | 0.48% |
3,150,352
-43,178
| -1% | -$404K |
|
43
Cannae Holdings
CNNE
$1.09B
| $27.3M | 0.44% |
1,430,248
| – | – |
|
44
Constellium
CSTM
$1.93B
| $24.8M | 0.4% |
1,523,832
-2,139,063
| -58% | -$34.8M |
|
45
scPharmaceuticals
SCPH
$296M
| $21.8M | 0.35% |
4,775,000
+1,250,000
| +35% | +$5.7M |
|
46
Ardelyx
ARDX
$1.57B
| $21.1M | 0.34% |
3,060,191
+1,243,606
| +68% | +$8.57M |
|
47
Trevi Therapeutics
TRVI
$871M
| $16.8M | 0.27% |
5,026,931
| – | – |
|
48
Riskified
RSKD
$712M
| $16M | 0.26% |
3,379,662
-793,974
| -19% | -$3.76M |
|
49
Embecta
EMBC
$837M
| $15.3M | 0.25% |
+1,085,529
| New | +$15.3M |
|
50
Telesat
TSAT
$307M
| $12.6M | 0.21% |
959,764
| – | – |
|